HCRT and cancer: A recent report focused on the connection between narcolepsy, Alzheimer’s and Parkinson’s diseases—where a dysregulation of orexin signaling was observed—and cancer, suggesting that the modulation of orexin signaling could have a putative therapeutic role in cancer treatment [14].